SUTRO’S COMMITMENT TO PATIENTS
Together, we can conquer the unconquerable.
Unrelenting, undiscriminating, and seemingly undefeatable – cancer. It’s time we tip the scales. Sutro Biopharma remains steadfast in the mission to revolutionize cancer treatments, aiming to not only extend life but significantly improve its quality. Harnessing the power of our groundbreaking technology, we stand at the forefront of rewriting the future of oncology.
In 2025, 2,041,910 new cancer cases and 618,120 cancer deaths are projected to occur in the United States.
Sutro and our employees are dedicated to improving survival and quality of life for cancer patients through our innovative research, discovery, development and manufacturing of novel cancer therapeutics.
We believe that Sutro’s revolutionary technology has the potential to change the future of oncology therapeutics; the Sutro team is purposeful in its quest to fully realize the potential of its technology. Sutro is uniquely positioned to chart a path that allows its technology to fully intervene in human disease in a way that no technology previously has. Together with its partners and investors, Sutro is discovering, developing and manufacturing important new therapeutics with a greater precision and a deeper understanding.